Congenital Hematological Disorder Completed Phase 1 Trials for Coagulation factor VIIa Recombinant Human (DB00036)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01949792A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without InhibitorsTreatment
NCT01561924Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of ThromboelastographyDiagnostic